Radius Health Company Profile (NASDAQ:RDUS)

About Radius Health

Radius Health logoRadius Health, Inc. is a biopharmaceutical company focused on developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Its product candidate, the investigational drug abaloparatide for subcutaneous injection, has completed Phase III development for use in the reduction of fracture risk in postmenopausal women with osteoporosis. Its clinical pipeline also includes an investigational abaloparatide transdermal patch for use in osteoporosis and the investigational drug RAD1901 for use in hormone-driven and hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its preclinical pipeline includes RAD140, a non-steroidal, selective androgen receptor modulator (SARM) under investigation for use in cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RDUS
  • CUSIP:
Key Metrics:
  • Previous Close: $56.52
  • 50 Day Moving Average: $55.24
  • 200 Day Moving Average: $41.35
  • 52-Week Range: $24.75 - $77.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.15
  • P/E Growth: -4.82
  • Market Cap: $2.43B
  • Outstanding Shares: 43,082,000
  • Beta: 1.33
Profitability:
  • Return on Equity: -32.94%
  • Return on Assets: -31.55%
Debt:
  • Current Ratio: 20.75%
  • Quick Ratio: 20.75%
Additional Links:
Companies Related to Radius Health:

Analyst Ratings

Consensus Ratings for Radius Health (NASDAQ:RDUS) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $61.50 (8.81% upside)

Analysts' Ratings History for Radius Health (NASDAQ:RDUS)
Show:
DateFirmActionRatingPrice TargetDetails
9/21/2016HC WainwrightBoost Price TargetBuy$55.00 -> $71.00View Rating Details
9/20/2016Jefferies GroupReiterated RatingHold$46.00View Rating Details
9/19/2016Canaccord GenuitySet Price TargetBuy$85.00View Rating Details
8/5/2016JPMorgan Chase & Co.Reiterated RatingBuy$70.00View Rating Details
8/4/2016Cowen and CompanyReiterated RatingBuyView Rating Details
8/4/2016Maxim GroupDowngradeHold -> Sell$24.00View Rating Details
3/31/2016Cantor FitzgeraldReiterated RatingBuy$70.00View Rating Details
3/30/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$37.00View Rating Details
1/25/2016Bank of America Corp.Reiterated RatingBuy$89.00View Rating Details
8/14/2015Deutsche Bank AGInitiated CoverageBuy$90.00View Rating Details
(Data available from 9/24/2014 forward)

Earnings

Earnings History for Radius Health (NASDAQ:RDUS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.95)($1.01)ViewN/AView Earnings Details
5/5/2016Q116($0.74)($0.94)ViewN/AView Earnings Details
2/25/2016Q415($0.64)($0.77)ViewListenView Earnings Details
11/5/2015Q315($0.58)($0.68)ViewN/AView Earnings Details
8/6/2015Q215($0.52)($0.61)ViewN/AView Earnings Details
5/6/2015Q115($0.52)($0.47)ViewN/AView Earnings Details
3/10/2015Q414($0.63)($0.55)ViewN/AView Earnings Details
11/10/2014Q314($0.65)($0.59)ViewN/AView Earnings Details
8/12/2014Q2($0.89)($2.22)$16.24 million$10.62 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Radius Health (NASDAQ:RDUS)
Current Year EPS Consensus Estimate: $-4.16 EPS
Next Year EPS Consensus Estimate: $-3.5 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.80)($0.79)($0.80)
Q2 20161($0.99)($0.99)($0.99)
Q3 20161($1.05)($1.05)($1.05)
Q4 20161($1.02)($1.02)($1.02)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Radius Health (NASDAQ:RDUS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Radius Health (NASDAQ:RDUS)
Insider Ownership Percentage: 16.80%
Institutional Ownership Percentage: 99.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/22/2016Growth N V BiotechMajor ShareholderBuy38,259$31.67$1,211,662.53View SEC Filing  
1/13/2016Growth N V BiotechMajor ShareholderBuy50,000$39.90$1,995,000.00View SEC Filing  
11/12/2015Gary HattersleyinsiderSell5,683$75.00$426,225.00View SEC Filing  
11/3/2015Gary HattersleyinsiderSell13,333$70.00$933,310.00View SEC Filing  
10/23/2015Gary HattersleyinsiderSell11,302$65.00$734,630.00View SEC Filing  
10/21/2015Gary HattersleyinsiderSell1,501$65.36$98,105.36View SEC Filing  
10/21/2015Rob WardCEOSell50,000$61.99$3,099,500.00View SEC Filing  
8/21/2015Growth N. V. Biotechmajor shareholderBuy100,000$64.00$6,400,000.00View SEC Filing  
8/17/2015Kurt GravesDirectorSell22,694$70.00$1,588,580.00View SEC Filing  
7/6/2015Kurt GravesDirectorSell25,000$69.48$1,737,000.00View SEC Filing  
6/18/2015Kurt GravesDirectorSell25,000$55.05$1,376,250.00View SEC Filing  
5/1/2015Growth N V BiotechMajor ShareholderBuy50,000$36.46$1,823,000.00View SEC Filing  
4/29/2015Growth N V BiotechMajor ShareholderBuy50,000$36.23$1,811,500.00View SEC Filing  
4/28/2015Growth N V BiotechMajor ShareholderBuy50,000$36.59$1,829,500.00View SEC Filing  
4/27/2015Growth N V BiotechMajor ShareholderBuy50,000$38.38$1,919,000.00View SEC Filing  
3/6/2015Growth N V BiotechMajor ShareholderBuy75,000$47.08$3,531,000.00View SEC Filing  
2/25/2015Growth N V BiotechMajor ShareholderBuy35,000$45.74$1,600,900.00View SEC Filing  
6/11/2014Morana Jovan-EmbiricosDirectorBuy587,500$8.00$4,700,000.00View SEC Filing  
6/6/2014Growth N V BiotechMajor ShareholderBuy1,000,000$8.00$8,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Radius Health (NASDAQ:RDUS)
DateHeadline
News IconBiotech Stocks To Put On Your Watch List: Radius Health, Inc. (NASDAQ:RDUS), Puma Biotechnology, Inc. (NYSE:PBYI) - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - September 22 at 6:42 PM
News IconHot Biotech Stocks To Watch Right Now: Radius Health, Inc. (RDUS), Halozyme Therapeutics, Inc. (HALO) - The Independent Republic (NASDAQ:RDUS)
theindependentrepublic.com - September 21 at 11:03 AM
News IconTop Biotechnology Stock Picking: Radius Health, Inc. (RDUS), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:RDUS)
theindependentrepublic.com - September 21 at 11:03 AM
streetinsider.com logoRadius Health (RDUS) Gives Presentation on Abaloparatide Transdermal Patch Development Program at ASBMR (NASDAQ:RDUS)
www.streetinsider.com - September 20 at 12:17 PM
nasdaq.com logoInteresting RDUS Put And Call Options For November 18th (NASDAQ:RDUS)
www.nasdaq.com - September 20 at 12:17 PM
News IconShares Observed Gapping Up Before Market Open: Radius Health, Inc. (NASDAQ:RDUS) - Post News (NASDAQ:RDUS)
www.kentuckypostnews.com - September 19 at 6:57 PM
News IconTrading the Biotech News: Radius Health (RDUS), Pacific Biosciences of California (NASDAQ:PACB) - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - September 19 at 6:57 PM
finance.yahoo.com logoRadius Presents Abaloparatide Transdermal Patch Development Program at American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting (NASDAQ:RDUS)
finance.yahoo.com - September 19 at 6:57 PM
4-traders.com logoRadius Health : Announces Publication of Additional Positive Results from the Phase 3 ACTIVE Trial of Abaloparatide-SC in JBMR (NASDAQ:RDUS)
www.4-traders.com - September 19 at 11:33 AM
globenewswire.com logoRadius Announces Publication of Additional Positive Results from ... - GlobeNewswire (press release) (NASDAQ:RDUS)
globenewswire.com - September 18 at 11:12 AM
publicnow.com logoRadius Announces Publication of Additional Positive Results from the Phase 3 ACTIVE Trial of Abaloparatide-SC in JBMR (NASDAQ:RDUS)
www.publicnow.com - September 18 at 11:12 AM
investornewswire.com logoRadius Health, Inc. (NASDAQ:RDUS) Posted A Surprise Factor Of -3.06 Percent - Investor Newswire (NASDAQ:RDUS)
www.investornewswire.com - September 15 at 7:04 PM
seekingalpha.com logoRadius Hopes For Big Break With Abaloparatide - Seeking Alpha (NASDAQ:RDUS)
seekingalpha.com - September 14 at 11:22 AM
capitalcube.com logoRadius Health, Inc. :RDUS-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016 (NASDAQ:RDUS)
www.capitalcube.com - September 14 at 11:22 AM
News IconThe Sell-side Consensus is in on Radius Health, Inc. (NASDAQ:RDUS); Earnings & Target Updates - National Daily Press (NASDAQ:RDUS)
www.nationaldailypress.com - September 9 at 11:47 AM
News IconHot Biotech Stocks Recap: Radius Health, Inc. (NASDAQ:RDUS), Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - September 8 at 6:44 PM
News IconTrading the Biotech News: Radius Health, Inc. (NASDAQ:RDUS), Incyte Corporation (NASDAQ:INCY) - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - September 8 at 6:44 PM
investopedia.com logo3 Stocks With Bullish Volume Divergences (RDUS, PKG) (NASDAQ:RDUS)
www.investopedia.com - September 7 at 7:08 PM
4-traders.com logoRadius Health : Announces Three Presentations on RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016 (NASDAQ:RDUS)
www.4-traders.com - August 31 at 12:15 PM
finance.yahoo.com logoRadius Health Announces Three Presentations on RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016 (NASDAQ:RDUS)
finance.yahoo.com - August 30 at 10:19 AM
News IconRadius Health, Inc.'s (RDUS): Hot Watch to Target - Hot Stocks Point (NASDAQ:RDUS)
www.hotstockspoint.com - August 27 at 6:18 PM
fool.com logo3 Biotech Stocks With Explosive Upside Potential (NASDAQ:RDUS)
www.fool.com - August 23 at 7:10 PM
News IconStocks Buzz: Radius Health Inc (NASDAQ:RDUS), Cerulean Pharma Inc (NASDAQ:CERU) - Post Registrar (NASDAQ:RDUS)
postregistrar.com - August 22 at 6:59 PM
investornewswire.com logoWill Radius Health, Inc. (NASDAQ:RDUS) Hit $70 Price Target? - Investor Newswire (NASDAQ:RDUS)
www.investornewswire.com - August 21 at 6:15 PM
finance.yahoo.com logoRADIUS HEALTH, INC. Financials (NASDAQ:RDUS)
finance.yahoo.com - August 18 at 7:20 PM
4-traders.com logoRadius Health : RDUS) Announces Positive Results of Phase 3 ACTIVE Trial Published in JAMA (NASDAQ:RDUS)
www.4-traders.com - August 18 at 10:04 AM
istreetwire.com logoThree Movers to Watch for: Radius Health, Inc. (RDUS), Deere & Company (DE), Sophiris Bio, Inc. (SPHS) - iStreetWire (NASDAQ:RDUS)
istreetwire.com - August 17 at 7:24 PM
streetinsider.com logoRadius Health (RDUS) Announces Publication of Positive Phase 3 ACTIVE Data in JAMA - StreetInsider.com (NASDAQ:RDUS)
www.streetinsider.com - August 17 at 10:03 AM
finance.yahoo.com logoRadius (RDUS) Osteoporosis Drug Positive in Phase III Study (NASDAQ:RDUS)
finance.yahoo.com - August 17 at 10:03 AM
4-traders.com logoRadius Health : JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis (NASDAQ:RDUS)
www.4-traders.com - August 16 at 7:10 PM
finance.yahoo.com logo11:01 am Radius Health announces that positive results from the Phase 3 ACTIVE trial were published in the Journal of the American Medical Association (NASDAQ:RDUS)
finance.yahoo.com - August 16 at 7:10 PM
finance.yahoo.com logoJAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis (NASDAQ:RDUS)
finance.yahoo.com - August 16 at 7:10 PM
News IconNews review of 2 biotech stocks: Radius Health, Inc. (NASDAQ:RDUS), ImmunoCellular Therapeutics, Ltd. (NYSEMKT ... - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - August 13 at 9:55 AM
investors.com logoRadius Health shares rise 10% on continued bid rumours (NASDAQ:RDUS)
www.proactiveinvestors.com - August 12 at 7:11 PM
News IconRadius Health Inc (NASDAQ:RDUS): Buying The Stock At Right Time In Important, We Bought At $39 (NASDAQ:RDUS)
www.marketnewscall.com - August 12 at 7:11 PM
thestreet.com logoRadius Health, Subject of Takeover Talk, Rises Again (NASDAQ:RDUS)
www.thestreet.com - August 10 at 10:11 AM
biz.yahoo.com logoRADIUS HEALTH, INC. Files SEC form 10-Q/A, Quarterly Report (NASDAQ:RDUS)
biz.yahoo.com - August 9 at 7:22 PM
News IconActive biotech company shares in the news: Radius Health, Inc. (NASDAQ:RDUS), ImmunoGen, Inc. (NASDAQ:IMGN) - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - August 8 at 11:48 AM
investornewswire.com logoStrong Sell Calls For Radius Health, Inc. (NASDAQ:RDUS) At 1 - Investor Newswire (NASDAQ:RDUS)
www.investornewswire.com - August 7 at 6:43 PM
News IconRadius Health Inc (NASDAQ:RDUS): It’s All About Timing To Make Massive Profit, Members Up In Short Term (NASDAQ:RDUS)
www.marketnewscall.com - August 6 at 9:48 AM
proactiveinvestors.co.uk logoMarket sees slow gains as oil climbs out of bear territory (NASDAQ:RDUS)
www.proactiveinvestors.co.uk - August 5 at 7:17 PM
finance.yahoo.com logoRadius Health (RDUS) Reports Wider-than-Expected Q2 Loss (NASDAQ:RDUS)
finance.yahoo.com - August 5 at 7:17 PM
finance.yahoo.com logoEdited Transcript of RDUS earnings conference call or presentation 4-Aug-16 12:00pm GMT (NASDAQ:RDUS)
finance.yahoo.com - August 5 at 7:17 PM
News IconTrading the Biotech News: Intrexon Corporation (NYSE:XON ... - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - August 5 at 10:07 AM
istreetwire.com logoStocks In Queue: American Eagle Outfitters, Inc. (AEO), Radius ... - iStreetWire (NASDAQ:RDUS)
istreetwire.com - August 4 at 7:35 PM
finance.yahoo.com logoRadius Health downgraded by Maxim Group (NASDAQ:RDUS)
finance.yahoo.com - August 4 at 7:35 PM
equities.com logoRadius Health Inc. (RDUS) is Trading Higher on Unusual Volume for August 02 - Equities.com (NASDAQ:RDUS)
www.equities.com - August 4 at 10:17 AM
sg.finance.yahoo.com logoRadius Health reports 2Q loss (NASDAQ:RDUS)
sg.finance.yahoo.com - August 4 at 10:17 AM
publicnow.com logoRadius Health Reports Second Quarter 2016 Financial and Operating Results (NASDAQ:RDUS)
www.publicnow.com - August 4 at 10:17 AM
biz.yahoo.com logoRADIUS HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:RDUS)
biz.yahoo.com - August 4 at 10:17 AM

Social

Radius Health (NASDAQ:RDUS) Chart for Saturday, September, 24, 2016


Last Updated on 9/24/2016 by MarketBeat.com Staff